Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03660189 · ClinicalTrials.gov registry record · NA
Two Bag System for Diabetic Ketoacidosis
A NA study, sponsored by MetroHealth Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 57
- Enrollment target
NCT03660189 is a NA study that was terminated before completion, run by MetroHealth Medical Center. The registered enrollment target is 57 participants.
The verdict
NCT03660189, a NA study, was terminated before completion, sponsored by MetroHealth Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
Study Summary
This is a study investigating the best way to treat diabetic ketoacidosis (DKA) with intravenous (IV) fluids in the hospital. The purpose of this study is to determine whether the "two bag" system of administering IV fluids for the treatment of adults with DKA leads to a shorter time requiring intravenous insulin (a shorter time to anion gap closure), when compared to usual care the traditional "one bag" system of IV fluids. Participants will be assigned randomly to either the usual care group or the "two bag" system group. Based on studies performed in the past, the investigators predict that patients treated with the two bag system of IV fluids for DKA will have a significantly shorter time requiring treatment with intravenous insulin when compared to the traditional one bag system.
Interventions
- OTHER Two bag system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2018-09-17 |
| Est. Completion | 2023-06-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03660189
The ClinicalTrials.gov registry entry for NCT03660189 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MetroHealth Medical Center, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Two bag system is the first listed.
NCT03660189 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03660189 about?
NCT03660189 is a clinical study titled "Two Bag System for Diabetic Ketoacidosis". This is a study investigating the best way to treat diabetic ketoacidosis (DKA) with intravenous (IV) fluids in the hospital. The purpose of this study is to determine whether the "two bag" system of administering IV fluids for the treatment of adults with DKA leads to a shorter time requiring intra...
What is the current status of trial NCT03660189?
This trial is currently terminated. It is a NA study. The enrollment target is 57 participants. The study started on 2018-09-17. Estimated completion is 2023-06-15.
What interventions are being tested in trial NCT03660189?
The interventions under investigation include: Two bag system (OTHER).
Who is sponsoring clinical trial NCT03660189?
This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.